📰 Systemic Therapy News
Page 6 - Systemic Therapy News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Systemic Therapy. Real-time updates on events, politics, business and more.
February 7, 2021
Shares of TG Therapeutics spiked 12% on Feb. 5 after the US Food and Drug Administration (FDA) approved Ukoniq (umbralisib), its investigational compound, for the treatment of adult patients with relapsed or refractory marginal zone lymphoma (MZL). The stock gained another 4% in Friday's after-hours trading. Specifically, the FDA granted approval for the treatment of Ukoniq in MZL patients who have received at least one prior anti-CD20 based regimen and adult patients with relapsed or refra...
February 3, 2021
ó stata avanzado; presentaciones orales para destacar los resultados de los estudios de fase 3 ACIS, TITAN y SPARTAN SOLO PARA MEDIOS DE COMUNICACIÓN MÉDICOS Y COMERCIALES FARMACÉUTICOS DE LA REGIÓN DE EMEA NO SE PERMITE LA DISTRIBUCIÓN EN EL BENELUX NI EN EL REINO UNIDO Janssen Pharmaceutical Companies de Johnson & Johnson ha anunciado hoy que destacará la solidez de su cartera de tumores sólidos en el Simposio sobre Cánceres Genitourinarios de la Sociedad Americana de Oncología Cl�...
February 2, 2021
Janssen to Highlight Robust Solid Tumor Portfolio and Pipeline at 2021 ASCO GU Multiple data presentations to show long-term benefit and consistency of ERLEADA® (apalutamide) in advanced prostate cancer; oral presentations to highlight Phase 3 ACIS, TITAN and SPARTAN study results News provided by Share this article Share this article RARITAN, N.J., Feb. 2, 2021 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson announced today it will highlight the depth of its solid t...